CDH1 and benign neoplasm: The decrease or deletion of the expression of E-cadherin leads to the loss of contact inhibition and unrestricted hyperplasia, the loss of intercellular junction with, stronger invasive ability, enhanced tumor cell diffusion and metastasis, as well as benign tumor malignant transformation in some extreme cases [21], [22], [23].